IGF2 and colorectal carcinoma: On the contrary, our results showed that IGF2 hypermethylation increases the risk of developing CRC, indicating that IGF2 participates in CRC tumorigenesis through two different modes of epigenetic alteration, aberrant hypermethylation and LOI, which is supported by previous studies (34, 35).